Target intelligence / Profile preview

Retinoid isomerohydrolase RPE65 (RPE65)

Target
RPE65
Molecular classification
Enzyme, Oxygenase, Visual cycle protein, Carotenoid oxygenase family
01

Overview

Retinoid isomerohydrolase RPE65 is an enzyme found in the retinal pigment epithelium that is essential for the visual cycle, specifically required for regenerating 11-cis-retinal from all-trans-retinyl esters; this step is crucial for phototransduction and sustaining normal vision. Mutations in the RPE65 gene are responsible for several inherited retinal diseases, including Leber congenital amaurosis and retinitis pigmentosa, leading to severe visual impairment or blindness. The enzyme's central role in vitamin A metabolism and retinal health has made it the target for gene therapy—for example, voretigene neparvovec, a gene addition therapy approved for patients with confirmed biallelic pathogenic RPE65 mutations[1][2][3][4].

Other names
Retinal pigment epithelium-specific 65 kDa proteinretinol isomeraseretinoid isomeraseRPE65 protein
02

Mechanism of action

Restoration of functional RPE65 activity (via gene addition therapy, such as voretigene neparvovec), facilitating the conversion of all-trans-retinyl esters to 11-cis-retinol for visual pigment regeneration

03

Biological functions

Visual cycle (retinoid/vitamin A cycle)PhototransductionRegeneration of visual pigments
04

Disease associations

Inherited retinal diseaseLeber congenital amaurosisRetinitis pigmentosaFundus albipunctatusOther retinal dystrophies
05

Safety considerations

Inherited gene therapy–specific risks (e.g., immune responses, ocular inflammation, loss of efficacy over time)potential for photoreceptor degeneration if untreated
06

Interacting drugs

Voretigene neparvovec (Luxturna)

1 more in the full profile.

07

Biomarkers

RPE65 gene mutation status (for patient selection for gene therapy in inherited retinal dystrophies)

Beyond the preview

Go deeper on Retinoid isomerohydrolase RPE65 (RPE65).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoid isomerohydrolase RPE65 (RPE65).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call